Ocrelizumab
Drug timelines are a Plus or Pro feature.
62 regulatory and trial events tracked for Ocrelizumab, covering 2015-03-25 to 2026-08-11. Get the full timeline:
Most recent: Clinical Trial Results: A Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple Sclerosis [Phase 3]